SEBI Reg. Investment Advisor

Download App
Help Center Pricing
Money Works 4 Me Logo MoneyWorks4Me
Login Get Free Account
Sign Up

MoneyWorks4Me

Log In Sign Up Schedule Free 15‑min Call
Login Get Free Account
Sign Up

INVESTMENT INSIGHTS

Check Before You Invest : 3B Blackbio Dx Ltd

BSE: 532067 NSE: ISIN: INE994E01018
  |   Sector:  Healthcare   |   Industry:  Medical Equipment/Supplies/Accessories

Snapshot

Q.1 Which industry/sub-sector does 3B Blackbio Dx Ltd belong to?
3B Blackbio Dx Ltd belongs to the Healthcare sector, operating specifically within the Medical Equipment/Supplies/Accessories segment.
Q.2 Is 3B Blackbio Dx Ltd a good quality company?
3B Blackbio Dx Ltd is a average quality company, based on a somewhat consistent 10 year financial track record.
Q.3 Is 3B Blackbio Dx Ltd undervalued or overvalued?
3B Blackbio Dx Ltd appears Fair, as its key valuation ratios are in line with their past averages.
Q.4 Is 3B Blackbio Dx Ltd a good buy now?
3B Blackbio Dx Ltd is not a good buy now, based on weak price trend analysis suggesting prices may fall. However, you need to check its quality and valuation before making a decision

Performance Analysis

Q.1 Revenue growth of 3B Blackbio Dx Ltd?
3B Blackbio Dx Ltd revenue growth is 28% for FY-2025 , which is below its 5 year CAGR of 46.3% , indicating slower growth.
Q.2 Gross Profit margin of 3B Blackbio Dx Ltd?
3B Blackbio Dx Ltd Gross profit margin which is the profit after deduction of direct costs, is 71.6% for FY-2025 , which is above its 5 year median of 56.4% , indicating increasing margins.
Q.3 Operating Profit Margin of 3B Blackbio Dx Ltd?
3B Blackbio Dx Ltd Operating Profit Margin which is the profit after deduction of all operating costs, is 55.07% for FY-2025 , which is above its 5 year median of -7.78% indicating increasing margins.
Q.4 Net Profit Margin of 3B Blackbio Dx Ltd?
3B Blackbio Dx Ltd Net Profit Margin is 52.53% for FY-2025 , is above with its 5 year median of 48.38%, indicating increasing margins.
Current Level Historic Median
Gross Profit Margin 71.6 56.4
Operating Profit Margin 55.07 -7.78
Net Profit Margin 52.53 48.38
Q.5 Return on Asset of 3B Blackbio Dx Ltd?
3B Blackbio Dx Ltd Return on Asset is 17.39%, which is in line with its 5 year historical median of 17.39%, indicating stable asset utilization efficiency.
Q.6 Return on Equity (ROE) of 3B Blackbio Dx Ltd?
3B Blackbio Dx Ltd Return on equity is 19% for FY-2025 , which is in line with its historical median of 19%, indicating the business is making similar use of its shareholders capital.
Q.7 Return on capital employed (ROCE) of 3B Blackbio Dx Ltd?
3B Blackbio Dx Ltd Return on capital employed is 25.53% for FY-2025 , which is above its estimated weighted average cost of capital(WACC) 14%, indicating value creation.
Q.8 Cash conversion cycle of 3B Blackbio Dx Ltd?
3B Blackbio Dx Ltd Cash conversion cycle is 149 days, below its historical median of 318 days, indicating improved working capital management. However, you need to compare this with its peers in the industry.
Current Level Historic Median
Asset Turnover 0.33 0.5
ROE 19 19
ROCE 25.53 25.53
Cash Conversion Cycle 149 days 318 days
Q.9 Debt to Equity ratio of 3B Blackbio Dx Ltd?
3B Blackbio Dx Ltd Debt-to-Equity ratio is 0.00 , which is lower with the industry average of 0.36 , indicating lower debt levels in the industry.
Q.10 Debt to cash flow from operations of 3B Blackbio Dx Ltd?
3B Blackbio Dx Ltd Debt to cash flow from operations is 0.01 , which is at a healthy level.

Ownership & governance

Q.1 Promoter shareholding and pledge status of 3B Blackbio Dx Ltd?
Promoters hold 40.94% of the 3B Blackbio Dx Ltd, with 0.00% of their stake pledged, indicating no pledge risk.

Peer comparison (industry-wise, mcap)

Q.1 Revenue growth of 3B Blackbio Dx Ltd vs industry peers?
3B Blackbio Dx Ltd revenue CAGR is 46.29% , compared to the industry median CAGR of 1.45% , indicating faster growth and gaining its market share.
Profit Metrics
Current Level Industry Median
Revenue 90.5 36.5
Gross Profit 65.2 4.1
Operating Profit 50 3.3
Net Profit 48 2.6
Operating Efficiency
Current Level Industry Median
Asset Turnover 0.33 0.73
ROE 19 15.79
ROCE 25.53 20.14
Cash Conversion Cycle (days) 149.48 86

Valuation & price assessment

Q.1 Stock return of 3B Blackbio Dx Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 64.6% based on the current price.
Q.2 What return has the stock given over the last decade?
9Y 5Y 3Y 1Y
Share Price 64.6% 32.1% 44.7% -26.5%
Q.3 Valuation ratios of 3B Blackbio Dx Ltd vs historical?
The current P/E is higher that its historical median.
Q.4 How do the current valuation ratios measure up against the historic numbers and the current industry numbers?
Valuation Ratios Current Historic Median Industry Median
Price to Earnings 20.93 0.00 148.25
Price to Book 3.43 11.05 3.50
Price to Sales 11.18 16.74 3.36
EV to EBITDA 14.68 0.00 19.40

Check more companies

1. Poly Medicure
2. 3B Blackbio Dx
3. Osel Devices
4. Laxmi Denta
5. Prevest Denpro
6. Hemant Surgical Inds
7. Yash Optics & Lens
8. Nureca Ltd.
9. Earkart
10. Raaj Medisafe India
2026 ©The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me® is a registered trademark of The Alchemists Ark Pvt. Ltd.

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×